Clinical Trial Detail

NCT ID NCT03783936
Title Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Michael Sangmin Lee
Indications

gastroesophageal adenocarcinoma

gastric adenocarcinoma

esophagus adenocarcinoma

Therapies

Avelumab + Trastuzumab

Avelumab + Fluorouracil + Leucovorin + Oxaliplatin + Trastuzumab

Age Groups: senior adult

Additional content available in CKB BOOST